1-9 of 9
Paul Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 2417: Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis

Michael Paul Kim, Xinqun Li, Jenying Deng, Yun Zhang, Bingbing Dai, Kendra Allton, Tara Hughes, Christian Siangco, Jithesh Augustine, Yaan Kang, Joy M. McDaniel, Shunbin Xiong, Eugene Koay, Florencia McAllister, Christopher Bristow, Timothy Heffernan, Anirban Maitra, Bin Liu, Michelle Barton, Amanda Wasylischen, Jason Fleming, Guillermina lozano
Journal: Cancer Research
Cancer Res (2021) 81 (13_Supplement): 2417.
https://doi.org/10.1158/1538-7445.AM2021-2417
Published: 01 July 2021
View articletitled, Abstract 2417: Mutant p53 and oncogenic KRAS converge on CREB1 to drive pancreatic cancer metastasis
Journal Articles

Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS

Heather Greenwood, Rita Freimanis, Case Brabham, Rita Mukhtar, Gillian Hirst, Paul Kim, April Liang, Laura Esserman, Nola Hylton, Amrita Basu
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PD5-01.
https://doi.org/10.1158/1538-7445.SABCS20-PD5-01
Published: 15 February 2021
View articletitled, Abstract PD5-01: Magnetic resonance imaging insights from an active surveillance cohort of women with DCIS
Journal Articles

Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up

Case Brabham, Rita Mukhtar, April Liang, Paul Kim, Gillian Hirst, Amrita Basu, Heather Greenwood, Rita Freimanis, Alexander Borowsky, Shelley Hwang, Rick Baehner, Gregor Krings, Nola Hylton, Laura Esserman
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS1-03.
https://doi.org/10.1158/1538-7445.SABCS20-PS1-03
Published: 15 February 2021
View articletitled, Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up
Journal Articles

Abstract PD9-06: Additive benefit of MRI background parenchymal enhancement (BPE) to an MRI tumor volume model for predicting pathologic complete response (pCR) to neoadjuvant treatment in ISPY2

Vignesh A. Arasu, Paul Kim, Wen Li, Fredrik Strand, Cody McHargue, Ella Jones, David Newitt, John Kornak, Laura Esserman, Nola Hylton, ACRIN 6657 Trial TeamI-SPY Investigators Network
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD9-06.
https://doi.org/10.1158/1538-7445.SABCS19-PD9-06
Published: 15 February 2020
View articletitled, Abstract PD9-06: Additive benefit of MRI background parenchymal enhancement (BPE) to an MRI tumor volume model for predicting pathologic complete response (pCR) to neoadjuvant treatment in ISPY2
Journal Articles

Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry

Jane M Wei, Paul Kim, Cheryl Ewing, Jasmine Wong, Laura J Esserman, Michael D Alvarado, Abimbola O Olusanya, Skye Stewart, Ashley Tydon, Parima Daroui, Jeffrey V Kuo, Hannah L Park, Karen T Lane, Eliza Jeong, Kelsey Brown, Ava Hosseini, Barbara A Parker, Sarah L Blair, Athena Breast Health Network Investigators, Frederick Baehner, Olivier Harismendy, Antonia Petruse, Carlie K Thompson, Helena R Chang, Alexander D Borowsky, Christina Yau, Gillian L Hirst, Richard J Bold, Rita A Mukhtar
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): OT3-09-01.
https://doi.org/10.1158/1538-7445.SABCS19-OT3-09-01
Published: 15 February 2020
View articletitled, Abstract OT3-09-01: Use of Oncotype DX DCIS for disease management in a prospective DCIS registry
Journal Articles

Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy

Paul Kim, Heather I. Greenwood, Rita I. Freimanis, Gillian L Hirst, Megan Fischer-Colbrie, Jessica Gibbs, Nola M Hylton, Christina Yau, Eun-Sil Shelley Hwang, Laura J. Esserman, Rita A Mukhtar
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P6-16-06.
https://doi.org/10.1158/1538-7445.SABCS19-P6-16-06
Published: 15 February 2020
View articletitled, Abstract P6-16-06: Improved early stratification of invasive cancer risk using MRI in a ductal carcinoma in-situ short-term active surveillance cohort treated with neoadjuvant endocrine therapy
Journal Articles

Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study

Thomas O'Keefe, Christina Yau, Eliza Jeong, Emma Iaconetti, Paul Kim, Ann Griffin, Joseph McGuire, Rita Mukhtar, Laura Esserman, Olivier Harismendy, Gillian L. Hirst
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): P5-08-05.
https://doi.org/10.1158/1538-7445.SABCS19-P5-08-05
Published: 15 February 2020
View articletitled, Abstract P5-08-05: Risk of subsequent events after initial diagnosis of ductal carcinoma in situ - A large multi-center registry study
Journal Articles

Abstract 1482: Early detection and longitudinal imaging of breast cancer metastatic microlesions using short-wave infrared light emitting rare-earth nanoprobes

Margot Zevon, Vidya Ganapathy, Harini Kantamneni, Marco Mingozzi, Paul Kim, Derek Adler, Mark Pierce, Richard Riman, Charles Roth, Prabhas Moghe
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1482.
https://doi.org/10.1158/1538-7445.AM2015-1482
Published: 01 August 2015
View articletitled, Abstract 1482: Early detection and longitudinal imaging of breast cancer metastatic microlesions using short-wave infrared light emitting rare-earth nanoprobes
Journal Articles

Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines

Douglas Boyd, Germaine Florent, Paul Kim, Michael Brattain
Journal: Cancer Research
Cancer Res (1988) 48 (11): 3112–3116.
Published: 01 June 1988
View articletitled, Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines
Open the PDF for Determination of the Levels of Urokinase and Its Receptor in Human Colon Carcinoma Cell Lines in another window